Patients with high-risk acute promyelocytic leukemia need maintenance therapy for 1 year - The PROS Editorial

   

Author:	Tallman, M. S.
Title:	Patients with high-risk acute promyelocytic leukemia need maintenance therapy for 1 year - The PROS
Keywords:	cancer survival; overall survival; cancer risk; disease free survival; methotrexate; maintenance therapy; editorial; cancer mortality; lymphoma; promyelocytic leukemia; leukocyte count; retinoic acid; gemtuzumab ozogamicin; recurrence free survival; clinical outcome; human; article; high risk acute promyelocytic leukemia
Journal Title:	Haematologica
Volume:	110
Issue:	7
ISSN:	0390-6078
Publisher:	Ferrata Storti Foundation
Date Published:	2025-07-01
Start Page:	1454
End Page:	1458
Language:	English
DOI:	10.3324/haematol.2025.287417
PUBMED:	40176767
PROVIDER:	scopus
PMCID:	PMC12209762
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-105009540960&doi=10.3324%2fhaematol.2025.287417&partnerID=40&md5=b1ae031d0a43d630a8a700170f072519
Notes:	Editorial -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/227255